Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/27186| Title: | Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply. | Austin Authors: | da Silva, Ines Pires;Ahmed, Tasnia;Reijers, Irene L M;Warner, Allison Betof;Patrinely, James Randall;Serra-Bellver, Patricio;Allayous, Clara;Mangana, Joanna;Zimmer, Lisa;Trojaniello, Claudia;Klein, Oliver ;Gerard, Camille L;Michielin, Olivier;Haydon, Andrew;Ascierto, Paolo A;Carlino, Matteo S;Lebbe, Celeste;Lorigan, Paul;Johnson, Douglas B;Sandhu, Shahneen;Lo, Serigne N;Menzies, Alexander M;Long, Georgina V | Affiliation: | Division of Cancer Services, The University of Manchester, Manchester, UK Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy Memorial Sloan Kettering Cancer Center, New York, NY, USA Vanderbilt University Medical Center, Nashville, TN, USA Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany The Netherlands Cancer Institute, Amsterdam, Netherlands Department of Dermatology, University Hospital Zurich, Zurich, Switzerland Oncology Department, Lausanne University Hospital, Lausanne, Switzerland AP-HP Dermatology, INSERM U976, Université de Paris, Saint Louis Hospital, Paris, France Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia Olivia Newton-John Cancer Research Institute Department of Medical Oncology, Alfred Hospital, Monash University, Melbourne, VIC, Australia Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia Peter MacCallum Cancer Centre, Melbourne, VIC, Australia |
Issue Date: | Aug-2021 | Publication information: | The Lancet. Oncology 2021; 22(8): e343-e344 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/27186 | DOI: | 10.1016/S1470-2045(21)00419-8 | Journal: | The Lancet. Oncology | PubMed URL: | 34339647 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.